Back to Trades
Neervannan Seshadri
Chief Operating OfficerCIK 0001827584
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 5
- Buy transactions
- 0
- Sell transactions
- 6
- Companies
- 1
- Active
- 2025–2026
Neervannan Seshadri, Chief Operating Officer, has filed 5 SEC reports (2025–2026), all concentrated in Tarsus Pharmaceuticals, Inc. (TARS), totaling $2.0M in disclosed volume. Weighing $0 bought versus $2.0M sold, the history is heavily weighted toward selling. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
5 loaded
| Sep 9 | TARS Tarsus Pharmaceuticals, Inc. | Neervannan Seshadri | Chief Operating Officer | Sell | $387.9K |
| Mar 24 | TARS Tarsus Pharmaceuticals, Inc. | Neervannan Seshadri | Chief Operating Officer | Sell | $199.5K |
| Mar 19 | TARS Tarsus Pharmaceuticals, Inc. | Neervannan Seshadri | Chief Operating Officer | Sell | $772.4K |
| Mar 5 | TARS Tarsus Pharmaceuticals, Inc. | Neervannan Seshadri | Chief Operating Officer | Sell | $641.4K |
| Dec 18 | TARS Tarsus Pharmaceuticals, Inc. | Neervannan Seshadri | Chief Operating Officer | Gift | $0 |
5 filings